We previously showed that type 2 diabetes patients have higher ADAMTS13 activity compared with controls [8, 23], which is inconsistent with a mechanism involving VWF’s prothrombotic function. This evidence concerns the gene ADAMTS13 and type 2 diabetes mellitus.